Rollins, Inc.
ROLLast close · Oct 16, 202633.45−0.44 (−1.30%)
Market cap$16.1B
7 firms' latest targets, last 90 days: median $36.00 ($27.00–$45.00), 8% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-14 | UBS | $36.00 | ▼ 16% | +8% |
| 2026-09-29 | Wells Fargo | $27.00 | ▼ 16% | -19% |
| 2026-09-23 | Piper Sandler | $33.00 | — | -1% |
| 2026-07-24 | Barclays | $45.00 | ▼ 37% | +35% |
| 2026-07-23 | Canaccord Genuity | $45.00 | ▼ 12% | +35% |
| 2026-07-23 | Raymond James | $35.00 | — | +5% |
| 2026-07-23 | RBC Capital | $40.00 | ▼ 40% | +20% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $3.1B | +14% | $0.89 | +19% | est. $3.1B+0% | est. $0.89 | 7 |
| 2024reported | $3.4B | +10% | $0.96 | +8% | est. $3.4B+0% | est. $0.98 | 8 |
| 2025reported | $3.8B | +11% | $1.09 | +14% | est. $3.8B+0% | est. $1.11 | 10 |
| 2026 | $4.1B | +9% | $1.17 | +5% | $4.1B–$4.2B | $1.14–$1.21 | 13 |
| 2027 | $4.4B | +9% | $1.29 | +10% | $4.3B–$4.6B | $1.26–$1.32 | 13 |
| 2028 | $4.8B | +8% | $1.43 | +11% | $4.6B–$4.9B | $1.37–$1.49 | 12 |
| 2029 | $5.2B | +9% | $1.62 | +13% | $5.1B–$5.3B | $1.57–$1.66 | 10 |
| 2030 | $5.4B | +4% | $1.67 | +3% | $5.3B–$5.5B | $1.63–$1.71 | 6 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.